Hypophosphatasia: Clinical manifestations, diagnostic recommendations and therapeutic options

Whyte, 2016, Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment, Nat Rev Endocrinol, 12, 233, 10.1038/nrendo.2016.14 Rockman-Greenberg, 2013, Hypophosphatasia, Pediatr Endocrinol Rev, 10, 380 Millan, 2016, Alkaline phosphatase. Hypophosphatasia, Calcif Tissue Int, 98, 398, 10.1007/s00223-015-0079-1 2017 Mornet, 2008, Hypophosphatasia, Best Pract Res Clin Rheumatol, 22, 113, 10.1016/j.berh.2007.11.003 Whyte, 2015, Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients, Bone, 75, 229, 10.1016/j.bone.2015.02.022 Taketani, 2014, Clinical and genetic aspects of hypophosphatasia in Japanese patients, Arch Dis Child, 99, 211, 10.1136/archdischild-2013-305037 Mornet, 2011, A molecular-based estimation of the prevalence of hypophosphatasia in the European population, Ann Hum Genet, 75, 439, 10.1111/j.1469-1809.2011.00642.x Whyte, 2012, Enzyme-replacement therapy in life-threatening hypophosphatasia, N Engl J Med, 366, 904, 10.1056/NEJMoa1106173 Whyte, 2016, Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia, J Clin Endocrinol Metab, 101, 334, 10.1210/jc.2015-3462 Whyte, 2010, Physiological role of alkaline phosphatase explored in hypophosphatasia, Ann N Y Acad Sci, 1192, 190, 10.1111/j.1749-6632.2010.05387.x Kozlowski, 1976, Hypophosphatasia. Review of 24 cases, Pediatr Radiol, 5, 103, 10.1007/BF00975316 Baumgartner-Sigl, 2007, Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene, Bone, 40, 1655, 10.1016/j.bone.2007.01.020 Sumner, 1984, Hypophosphatasia and nephrocalcinosis demonstrated by ultrasound and CT, Clin Nephrol, 22, 317 Mornet, 2007, Hypophosphatasia orphanet, J Rare Dis, 2, 40, 10.1186/1750-1172-2-40 Silva, 2012, Childhood hypophosphatasia with myopathy: clinical report with recent update, Acta Reumatol Port, 37, 92 Whyte, 2016, Asfotase alfa therapy for children with hypophosphatasia, JCI Insight, 1, e85971, 10.1172/jci.insight.85971 Whyte, 2017, Hypophosphatasia. enzyme replacement therapy brings new opportunities and new challenges, J Bone Miner Res, 32, 667, 10.1002/jbmr.3075 European Medicines Agency, 2017, Strensiq: EPAR-Product Information, Biomass, 1 Watanabe, 2007, Prenatal genetic diagnosis of severe perinatal (lethal) hypophosphatasia, J Nippon Med Sch, 74, 65, 10.1272/jnms.74.65 Silver, 1988, Pulmonary hypoplasia in neonatal hypophosphatasia, Pediatr Pathol, 8, 483, 10.3109/15513818809022304 Collmann, 2009, Neurosurgical aspects of childhood hypophosphatasia, Childs Nerv Syst, 25, 217, 10.1007/s00381-008-0708-3 Seshia, 1990, Myopathy with hypophosphatasia, Arch Dis Child, 65, 130, 10.1136/adc.65.1.130 Colantonio, 2012, Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children, Clin Chem, 58, 854, 10.1373/clinchem.2011.177741 2007 Estey, 2013, CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort, Clin Biochem, 46, 1197, 10.1016/j.clinbiochem.2013.04.001 2009 Instructions for use VITROS Chemistry Products ALKP Slide. Rochester, NY: Ortho-Clinical Diagnostics, Inc. Report No.: MP2-37_EN. 2003